Houston, United States
DELIVER Therapeutics, Inc. is a biopharma and biotechnology startup founded in 2020 with its headquarters in the United States. The company's slogan, "Applying high throughput screening technologies to deliver novel therapeutics," reflects its focus on utilizing high throughput DNA encoded library (DEL) drug screening and other advanced technologies to develop small molecule and peptide therapeutics. DELIVER Therapeutics is dedicated to addressing challenging and previously termed "undruggable" targets in clinical medicine.
As of now, there is no public record of the company's last investment or the involved investors. However, the innovative approach and the potential of its technology in addressing unmet medical needs make DELIVER Therapeutics an intriguing prospect for venture capital firms seeking opportunities in the biopharma and biotechnology sectors.
